Characteristic molecular signature for the early detection and prediction of polycyclic aromatic hydrocarbons in rat liver

Toxicology Letters

Volumn 216, Issue 1, 2013, Pages 1-8

  Jung, Kwang Hwa ^a   Kim, Jeong Kyu ^a   Noh, Ji Heon ^a   Eun, Jung Woo ^a   Bae, Hyun Jin ^a   Kim, Min Gyu ^a   Chang, Young Gyoon ^a   Shen, Qingyu ^a   Kim, Seung Jin ^a   Kwon, So Hee ^b   Park, Won Sang ^a   Lee, Jung Young ^a   Nam, Suk Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Molecular marker; Molecular signature; Polycyclic aromatic hydrocarbons; Predictive toxicology

Indexed keywords

BENZ[A]ANTHRACENE; BENZO[A]PYRENE; MOLECULAR MARKER; NAPHTHALENE; PHENANTHRENE; POLYCYCLIC AROMATIC HYDROCARBON;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION PROFILING; GENOTOXICITY; HEALTH HAZARD; MALE; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; RAT; TRANSCRIPTOMICS;

ANIMALS; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; LETHAL DOSE 50; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; POLYCYCLIC HYDROCARBONS, AROMATIC; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84870529797     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.11.001     Document Type: Article

References (47)

1. Abdo K.M., Grumbein S., Chou B.J., Herbert R. Toxicity and carcinogenicity study in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhalation Toxicology 2001, 13:931-950.
2. Arfsten D.P., Schaeffer D.J., Mulveny D.C. The effects of near ultraviolet radiation on the toxic effects of polycyclic aromatic hydrocarbons in animals and plants: a review. Ecotoxicology and Environment Safety 1996, 33:1-24.
3. ATSDR Toxicological Profile for Naphthalene, 1-Methylnaphthalene, and 2-Methylnaphthalene 2005, US Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA, pp. 1-291.
4. Blaha L., Kapplova P., Vondracek J., Upham B., Machala M. Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons. Toxicological Sciences 2002, 65:43-51.
5. Bols N.C., Schirmer K., Joyce E.M., Dixon D.G., Greenberg B.M., Whyte J.J. Ability of polycyclic aromatic hydrocarbons to induce 7-ethoxyresorufin-o-deethylase activity in a trout liver cell line. Ecotoxicology and Environment Safety 1999, 44:118-128.
6. Burczynski M.E., Lin H.K., Penning T.M. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Research 1999, 59:607-614.
7. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Research 1982, 42:4875-4917.
8. Dipple A. DNA adducts of chemical carcinogens. Carcinogenesis 1995, 16:437-441.
9. Duggan D.J., Bittner M., Chen Y., Meltzer P., Trent J.M. Expression profiling using cDNA microarrays. Nature Genetics 1999, 21:10-14.
10. Durant J.L., Busby W.F., Lafleur A.L., Penman B.W., Crespi C.L. Human cell mutagenicity of oxygenated, nitrated and unsubstituted polycyclic aromatic hydrocarbons associated with urban aerosols. Mutation Research 1996, 371:123-157.
11. EPA U. Toxicological Review of Naphthalene 1998, US Environmental Protection Agency, Washington, DC, USA, pp. 1-42.
12. Eun J.W., Kwack S.J., Noh J.H., Jung K.H., Kim J.K., Bae H.J., Xie H., Ryu J.C., Ahn Y.M., Park W.S., Lee J.Y., Rhee G.S., Nam S.W. Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis. Toxicology Letters 2010, 195:60-67.
13. Eun J.W., Ryu S.Y., Noh J.H., Lee M.J., Jang J.J., Ryu J.C., Jung K.H., Kim J.K., Bae H.J., Xie H., Kim S.Y., Lee S.H., Park W.S., Yoo N.J., Lee J.Y., Nam S.W. Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis. Toxicology 2008, 249:176-183.
14. Hamadeh H.K., Bushel P.R., Jayadev S., Martin K., DiSorbo O., Sieber S., Bennett L., Tennant R., Stoll R., Barrett J.C., Blanchard K., Paules R.S., Afshari C.A. Gene expression analysis reveals chemical-specific profiles. Toxicological Sciences 2002, 67:219-231.
15. Hankinson O. The aryl hydrocarbon receptor complex. Annual Review of Pharmacology and Toxicology 1995, 35:307-340.
16. Hecht S.S., Chen M., Yagi H., Jerina D.M., Carmella S.G. r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. Cancer Epidemiology, Biomarkers & Prevention 2003, 12:1501-1508.
17. IARC, 2002. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer 82, pp. 1-556.
18. IARC, 2010. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer 92, pp. 1-853.
19. Jung K.H., Noh J.H., Eun J.W., Kim J.K., Bae H.J., Xie H., Jang J.J., Ryu J.C., Park W.S., Lee J.Y., Nam S.W. Molecular signature for early detection and prediction of polycyclic aromatic hydrocarbons in peripheral blood. Environmental Science and Technology 2011, 45:300-306.
20. Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Safety: An International Journal of Medical Toxicology and Drug Experience 2001, 24:483-490.
21. Kim J.K., Jung K.H., Noh J.H., Eun J.W., Bae H.J., Xie H.J., Jang J.J., Ryu J.C., Park W.S., Lee J.Y., Nam S.W. Identification of characteristic molecular signature for volatile organic compounds in peripheral blood of rat. Toxicology and Applied Pharmacology 2011, 250:162-169.
22. Kim Y.S., Min J., Hong H.N., Park J.H., Park K.S., Gu M.B. Gene expression analysis and classification of mode of toxicity of polycyclic aromatic hydrocarbons (PAHs) in Escherichia coli. Chemosphere 2007, 66:1243-1248.
23. Lang M., Pelkonen O. Metabolism of xenobiotics and chemical carcinogenesis. IARC Scientific Publications 1999, 13-22.
24. Machala M., Vondracek J., Blaha L., Ciganek M., Neca J.V. Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay. Mutation Research 2001, 497:49-62.
25. Maggioli J., Hoover A., Weng L. Toxicogenomic analysis methods for predictive toxicology. Journal of Pharmacological and Toxicological Methods 2006, 53:31-37.
26. Marvin C.H., McCarry B.E., Lundrigan J.A., Roberts K., Bryant D.W. Bioassay-directed fractionation of PAH of molecular mass 302 in coal tar-contaminated sediment. Science of the Total Environment 1999, 231:135-144.
27. Nam S.W., Park J.Y., Ramasamy A., Shevade S., Islam A., Long P.M., Park C.K., Park S.E., Kim S.Y., Lee S.H., Park W.S., Yoo N.J., Liu E.T., Miller L.D., Lee J.Y. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005, 42:809-818.
28. Novoradovskaya N., Whitfield M.L., Basehore L.S., Novoradovsky A., Pesich R., Usary J., Karaca M., Wong W.K., Aprelikova O., Fero M., Perou C.M., Botstein D., Braman J. Universal Reference RNA as a standard for microarray experiments. BMC Genomics 2004, 5:20.
29. NTP, 2004. Report on Carcinogens - Naphthalene, Eleventh Edition. US Department of Health and Human Services, Public Health Service, National Toxicology Program, pp. 1-4.
30. Park J.Y., Kim S.Y., Lee J.H., Song J., Noh J.H., Lee S.H., Park W.S., Yoo N.J., Lee J.Y., Nam S.W. Application of amplified RNA and evaluation of cRNA targets for spotted-oligonucleotide microarray. Biochemical and Biophysical Research Communications 2004, 325:1346-1352.
31. Perera F.P. Environment and cancer: who are susceptible?. Science 1997, 278:1068-1073.
32. Phillips D.H. Fifty years of benzo(a)pyrene. Nature 1983, 303:468-472.
33. Poirier M.C. Chemical-induced DNA damage and human cancer risk. Nature Reviews Cancer 2004, 4:630-637.
34. Ramesh A., Walker S.A., Hood D.B., Guillen M.D., Schneider K., Weyand E.H. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. International Journal of Toxicology 2004, 23:301-333.
35. Roos P.H., Tschirbs S., Pfeifer F., Welge P., Hack A., Wilhelm M., Bolt H.M. Risk potentials for humans of original and remediated PAH-contaminated soils: application of biomarkers of effect. Toxicology 2004, 205:181-194.
36. Rummel A.M., Trosko J.E., Wilson M.R., Upham B.L. Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity. Toxicological Sciences 1999, 49:232-240.
37. Safe S., Wang F., Porter W., Duan R., McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicology letters 1998, 102-103:343-347.
38. Saunders C.R., Ramesh A., Shockley D.C. Modulation of neurotoxic behavior in F-344 rats by temporal disposition of benzo(a)pyrene. Toxicology Letters 2002, 129:33-45.
39. Solhaug A., Refsnes M., Lag M., Schwarze P.E., Husoy T., Holme J.A. Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis 2004, 25:809-819.
40. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15545-15550.
41. 2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis 1997, 18:1177-1182.
42. Treinen-Moslen M. Toxic responses of the liver. Casarett and Doul's Toxicology: The Basic Science of Poisons 2001, 471-489. McGraw-Hill, New York. K. Klaassen (Ed.).
43. Ulrich R., Friend S.H. Toxicogenomics and drug discovery: will new technologies help us produce better drugs?. Nature Reviews Drug Discovery 2002, 1:84-88.
44. Wammer K.H., Peters C.A. Polycyclic aromatic hydrocarbon biodegradation rates: a structure-based study. Environmental Science and Technology 2005, 39:2571-2578.
45. Weisburger E.K. Metabolism and activation of chemical carcinogens. Molecular and Cellular Biochemistry 1980, 32:95-104.
46. Willett K.L., Wassenberg D., Lienesch L., Reichert W., Di Giulio R.T. In vivo and in vitro inhibition of CYP1A-dependent activity in Fundulus heteroclitus by the polynuclear aromatic hydrocarbon fluoranthene. Toxicology and Applied Pharmacology 2001, 177:264-271.
47. Xue W., Warshawsky D. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicology and Applied Pharmacology 2005, 206:73-93.